OLIGONUCLEOTIDES COMPRISING HOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE
To provide oligonucleotides with improved physiochemical and pharmacological properties.SOLUTION: Provided herein is an antisense gapmer oligonucleotide of formula (IA) or (IB) comprising at least one phosphorodithioate internucleoside linkage for inhibiting target RNA in a cell, where in the formul...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LARS JOENSON ERIK FUNDER KONRAD BLEICHER HENRIK FRYDENLUND HANSEN TROELS KOCH WU YONG MARTINA BRIGITTE DUSCHMALE ADRIAN SCHAEUBLIN JOERG DUSCHMALE SHU XI JESPER WORM LI MEILING |
| description | To provide oligonucleotides with improved physiochemical and pharmacological properties.SOLUTION: Provided herein is an antisense gapmer oligonucleotide of formula (IA) or (IB) comprising at least one phosphorodithioate internucleoside linkage for inhibiting target RNA in a cell, where in the formula, R is hydrogen or a phosphate-protecting group, and M+ is a cation, e.g., a metal cation, e.g., an alkali metal cation, e.g., a Na+ or K+ cation; or M+ is an ammonium cation.SELECTED DRAWING: None
【課題】改良された生理化学的特性及び薬理学的特性を有するオリゴヌクレオチドを提供する。【解決手段】式(IA)または(IB)TIFF2024041886000100.tif45128の少なくとも1個のホスホロジチオアートヌクレオシド間結合を含む、細胞において標的RNAを阻害するためのアンチセンスギャップマーオリゴヌクレオチドであって、式中、Rは、水素またはリン酸保護基であり、かつ、M+は、陽イオン、例えば金属陽イオン、例えばアルカリ金属陽イオン、例えばNa+陽イオンもしくはK+陽イオンであるか、またはM+は、アンモニウム陽イオンである、前記アンチセンスギャップマーオリゴヌクレオチドを提供する。【選択図】なし |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2024041886A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2024041886A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2024041886A3</originalsourceid><addsrcrecordid>eNrjZHD19_F09_cLdfZx9Q_xdHENVnD29w0I8gz29HNX8PAPDvDwD_J38Qzx8PR3DHFV8PQLcQ2CqA4Gqlbw8fTzdnR35WFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgZGJgYmhhYWZo7GRCkCAEZxLU8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>OLIGONUCLEOTIDES COMPRISING HOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE</title><source>esp@cenet</source><creator>LARS JOENSON ; ERIK FUNDER ; KONRAD BLEICHER ; HENRIK FRYDENLUND HANSEN ; TROELS KOCH ; WU YONG ; MARTINA BRIGITTE DUSCHMALE ; ADRIAN SCHAEUBLIN ; JOERG DUSCHMALE ; SHU XI ; JESPER WORM ; LI MEILING</creator><creatorcontrib>LARS JOENSON ; ERIK FUNDER ; KONRAD BLEICHER ; HENRIK FRYDENLUND HANSEN ; TROELS KOCH ; WU YONG ; MARTINA BRIGITTE DUSCHMALE ; ADRIAN SCHAEUBLIN ; JOERG DUSCHMALE ; SHU XI ; JESPER WORM ; LI MEILING</creatorcontrib><description>To provide oligonucleotides with improved physiochemical and pharmacological properties.SOLUTION: Provided herein is an antisense gapmer oligonucleotide of formula (IA) or (IB) comprising at least one phosphorodithioate internucleoside linkage for inhibiting target RNA in a cell, where in the formula, R is hydrogen or a phosphate-protecting group, and M+ is a cation, e.g., a metal cation, e.g., an alkali metal cation, e.g., a Na+ or K+ cation; or M+ is an ammonium cation.SELECTED DRAWING: None
【課題】改良された生理化学的特性及び薬理学的特性を有するオリゴヌクレオチドを提供する。【解決手段】式(IA)または(IB)TIFF2024041886000100.tif45128の少なくとも1個のホスホロジチオアートヌクレオシド間結合を含む、細胞において標的RNAを阻害するためのアンチセンスギャップマーオリゴヌクレオチドであって、式中、Rは、水素またはリン酸保護基であり、かつ、M+は、陽イオン、例えば金属陽イオン、例えばアルカリ金属陽イオン、例えばNa+陽イオンもしくはK+陽イオンであるか、またはM+は、アンモニウム陽イオンである、前記アンチセンスギャップマーオリゴヌクレオチドを提供する。【選択図】なし</description><language>eng ; jpn</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; DERIVATIVES THEREOF ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; SUGARS ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240327&DB=EPODOC&CC=JP&NR=2024041886A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240327&DB=EPODOC&CC=JP&NR=2024041886A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LARS JOENSON</creatorcontrib><creatorcontrib>ERIK FUNDER</creatorcontrib><creatorcontrib>KONRAD BLEICHER</creatorcontrib><creatorcontrib>HENRIK FRYDENLUND HANSEN</creatorcontrib><creatorcontrib>TROELS KOCH</creatorcontrib><creatorcontrib>WU YONG</creatorcontrib><creatorcontrib>MARTINA BRIGITTE DUSCHMALE</creatorcontrib><creatorcontrib>ADRIAN SCHAEUBLIN</creatorcontrib><creatorcontrib>JOERG DUSCHMALE</creatorcontrib><creatorcontrib>SHU XI</creatorcontrib><creatorcontrib>JESPER WORM</creatorcontrib><creatorcontrib>LI MEILING</creatorcontrib><title>OLIGONUCLEOTIDES COMPRISING HOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE</title><description>To provide oligonucleotides with improved physiochemical and pharmacological properties.SOLUTION: Provided herein is an antisense gapmer oligonucleotide of formula (IA) or (IB) comprising at least one phosphorodithioate internucleoside linkage for inhibiting target RNA in a cell, where in the formula, R is hydrogen or a phosphate-protecting group, and M+ is a cation, e.g., a metal cation, e.g., an alkali metal cation, e.g., a Na+ or K+ cation; or M+ is an ammonium cation.SELECTED DRAWING: None
【課題】改良された生理化学的特性及び薬理学的特性を有するオリゴヌクレオチドを提供する。【解決手段】式(IA)または(IB)TIFF2024041886000100.tif45128の少なくとも1個のホスホロジチオアートヌクレオシド間結合を含む、細胞において標的RNAを阻害するためのアンチセンスギャップマーオリゴヌクレオチドであって、式中、Rは、水素またはリン酸保護基であり、かつ、M+は、陽イオン、例えば金属陽イオン、例えばアルカリ金属陽イオン、例えばNa+陽イオンもしくはK+陽イオンであるか、またはM+は、アンモニウム陽イオンである、前記アンチセンスギャップマーオリゴヌクレオチドを提供する。【選択図】なし</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>DERIVATIVES THEREOF</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>SUGARS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHD19_F09_cLdfZx9Q_xdHENVnD29w0I8gz29HNX8PAPDvDwD_J38Qzx8PR3DHFV8PQLcQ2CqA4Gqlbw8fTzdnR35WFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgZGJgYmhhYWZo7GRCkCAEZxLU8</recordid><startdate>20240327</startdate><enddate>20240327</enddate><creator>LARS JOENSON</creator><creator>ERIK FUNDER</creator><creator>KONRAD BLEICHER</creator><creator>HENRIK FRYDENLUND HANSEN</creator><creator>TROELS KOCH</creator><creator>WU YONG</creator><creator>MARTINA BRIGITTE DUSCHMALE</creator><creator>ADRIAN SCHAEUBLIN</creator><creator>JOERG DUSCHMALE</creator><creator>SHU XI</creator><creator>JESPER WORM</creator><creator>LI MEILING</creator><scope>EVB</scope></search><sort><creationdate>20240327</creationdate><title>OLIGONUCLEOTIDES COMPRISING HOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE</title><author>LARS JOENSON ; ERIK FUNDER ; KONRAD BLEICHER ; HENRIK FRYDENLUND HANSEN ; TROELS KOCH ; WU YONG ; MARTINA BRIGITTE DUSCHMALE ; ADRIAN SCHAEUBLIN ; JOERG DUSCHMALE ; SHU XI ; JESPER WORM ; LI MEILING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2024041886A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>DERIVATIVES THEREOF</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>SUGARS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>LARS JOENSON</creatorcontrib><creatorcontrib>ERIK FUNDER</creatorcontrib><creatorcontrib>KONRAD BLEICHER</creatorcontrib><creatorcontrib>HENRIK FRYDENLUND HANSEN</creatorcontrib><creatorcontrib>TROELS KOCH</creatorcontrib><creatorcontrib>WU YONG</creatorcontrib><creatorcontrib>MARTINA BRIGITTE DUSCHMALE</creatorcontrib><creatorcontrib>ADRIAN SCHAEUBLIN</creatorcontrib><creatorcontrib>JOERG DUSCHMALE</creatorcontrib><creatorcontrib>SHU XI</creatorcontrib><creatorcontrib>JESPER WORM</creatorcontrib><creatorcontrib>LI MEILING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LARS JOENSON</au><au>ERIK FUNDER</au><au>KONRAD BLEICHER</au><au>HENRIK FRYDENLUND HANSEN</au><au>TROELS KOCH</au><au>WU YONG</au><au>MARTINA BRIGITTE DUSCHMALE</au><au>ADRIAN SCHAEUBLIN</au><au>JOERG DUSCHMALE</au><au>SHU XI</au><au>JESPER WORM</au><au>LI MEILING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>OLIGONUCLEOTIDES COMPRISING HOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE</title><date>2024-03-27</date><risdate>2024</risdate><abstract>To provide oligonucleotides with improved physiochemical and pharmacological properties.SOLUTION: Provided herein is an antisense gapmer oligonucleotide of formula (IA) or (IB) comprising at least one phosphorodithioate internucleoside linkage for inhibiting target RNA in a cell, where in the formula, R is hydrogen or a phosphate-protecting group, and M+ is a cation, e.g., a metal cation, e.g., an alkali metal cation, e.g., a Na+ or K+ cation; or M+ is an ammonium cation.SELECTED DRAWING: None
【課題】改良された生理化学的特性及び薬理学的特性を有するオリゴヌクレオチドを提供する。【解決手段】式(IA)または(IB)TIFF2024041886000100.tif45128の少なくとも1個のホスホロジチオアートヌクレオシド間結合を含む、細胞において標的RNAを阻害するためのアンチセンスギャップマーオリゴヌクレオチドであって、式中、Rは、水素またはリン酸保護基であり、かつ、M+は、陽イオン、例えば金属陽イオン、例えばアルカリ金属陽イオン、例えばNa+陽イオンもしくはK+陽イオンであるか、またはM+は、アンモニウム陽イオンである、前記アンチセンスギャップマーオリゴヌクレオチドを提供する。【選択図】なし</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; jpn |
| recordid | cdi_epo_espacenet_JP2024041886A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DERIVATIVES THEREOF ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS SUGARS VINEGAR WINE |
| title | OLIGONUCLEOTIDES COMPRISING HOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T16%3A22%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LARS%20JOENSON&rft.date=2024-03-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2024041886A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |